Panelist: José Antonio Burón Vidal Regional Medical Head, Europe Novartis
Panelist: Amy Van Sant President, Medical Affairs Ashfield Engage
Panelist: Judy Kando VP, Head of Medical and Clinical Tris Pharma
Panelist: Richard Crookes Principal Performance Director Ashfield Engage
Panelist: Suzanne Giordano Vice President, Head of Field Medical Sunovion Pharmaceuticals
Moderator: Paul Simms Independent
Of all the trends and transformations accelerated by the pandemic, the increasing importance and value of the Medical Science Liaison (MSL) is one of the most exciting.
Those in pharma that have increased faith and investment into their medical field teams, fostering their transformation from a supporting role to strategic value drivers, are now increasingly able to create new and stronger relationships throughout medical and scientific communities.
In our latest webinar, we will bring medical affairs leaders together to share their vision for the evolved MSL, how best to develop the new skills required, and what wider infrastructure capabilities are needed to ensure MSLs can provide yet more HCP value.
Key learnings include: